Brazil vs Liberia: Population requiring preventive chemotherapy for schistosomiasis
Brazil
2.21 million
in 2024
Liberia
2.49 million
in 2024
Brazil rank
29th
Liberia rank
28th
Population requiring preventive chemotherapy for schistosomiasis over time
- Brazil
- Liberia
How they compare
Liberia currently reports 2.49 million against 2.21 million in Brazil, a difference of 277,980.
That makes Liberia's figure about 1.1 times Brazil's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Brazil ahead.
Brazil ranks 29th and Liberia ranks 28th of 52 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.52 million | 1.12 million | 393,074 | Brazil |
| 2020s | 2.20 million | 1.42 million | 778,317 | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Brazil or Liberia?
- Liberia, at 2.49 million against 2.21 million in Brazil as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Brazil and Liberia?
- 277,980, with Liberia ahead.
- How many years of comparable data are there for Brazil and Liberia?
- 15 years are reported by both, from 2010 to 2024.
- How do Brazil and Liberia rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Brazil ranks 29th and Liberia ranks 28th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.